SafeBeat Rx

SafeBeat Rx CTO and President, Dr. Kunj Patel, presents at DeviceTalks Boston 2023

Medtech Innovator recently held their DeviceTalks Boston 2023 conference, an annual speaker-oriented showcase focused on exposing next-generation innovation in the medical device industry. DeviceTalks has multiple channels to facilitate connections and sharing of ideas in the medtech community, including various podcasts, virtual presentations, and conferences. SafeBeat’s co-founder, president, and CTO, Dr. Kunj Patel, had the… Continue reading SafeBeat Rx CTO and President, Dr. Kunj Patel, presents at DeviceTalks Boston 2023

SafeBeat Rx UCSF Clinical Trial begins Enrollment

In March, we began our UCSF clinical trial, which focuses on obtaining real user feedback on our application and reviewing algorithm results against the UCSF providers. The SafeBeat application aims to streamline provider and patient communication by providing an analysis on data acquired from FDA cleared hardware. To date, we have successfully enrolled several patients… Continue reading SafeBeat Rx UCSF Clinical Trial begins Enrollment

Vinko Buble has joined as Head of Backend Engineering

We are thrilled to welcome Vinko Buble to SafeBeat Rx as our new Head of Backend Engineering!  Vinko has had over two decades of experience as a Full Stack Software Engineer, Architect, and Senior Engineering Manager and has worked with some of the biggest names in tech–including Where Inc, Reversing Labs, and Noom Inc. His… Continue reading Vinko Buble has joined as Head of Backend Engineering

SafeBeat Rx CEO, Dr. Rachita Navara, presents at annual Heart Rhythm Society Conference

In a remarkable milestone for SafeBeat, Dr. Rachita Navara, the esteemed co-founder of SafeBeat, presented at the Heart Rhythm Society’s annual conference, the largest arrhythmia conference in the world. During SafeBeat’s first year of research submissions, Dr. Navara presented three abstracts over the course of three consecutive days. Her groundbreaking work focused on the application… Continue reading SafeBeat Rx CEO, Dr. Rachita Navara, presents at annual Heart Rhythm Society Conference

SafeBeat Rx

MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization’s flagship four-month Accelerator program, featuring medical device, diagnostic, and digital health technologies from around the globe

SafeBeat Rx CEO, Dr. Rachita Navara, recognized for AI Leadership & Entrepreneurship Awards by VentureBeat

Since 2019, VentureBeat has been honoring the women leaders, mentors, researchers and entrepreneurs who are transforming the AI industry

The Pulse Celebrates SafeBeat Rx CEO, Dr. Rachita Navara

Rachita Navara, CEO and cofounder of Safebeat RX, received a first funding of $120K. SafeBeat Rx replaces a hospitalization with a take-home kit that combines FDA-approved wearables with life-saving ECG software that expands access to proven heart therapies.

SafeBeat Rx featured as top YCombinator S21 startup by TechCrunch

Our favorite startups from YC’s Summer 21 Demo Day

Zillionize Invests in SafeBeat Rx

Zillionize Invests in SafeBeat Rx – Using cutting-edge engineering to transform cardiac care

Olin College of Engineering recognizes SafeBeat Rx CEO, Dr. Rachita Navara

As valedictorian and Outstanding Senior Student at the acclaimed Signature School in Indiana, Dr. Rachita Navara ’11 had her pick of top engineering schools from MIT to Caltech—but for her, Olin stood out from all the rest